The future of precision oncology rests largely in molecularly profiling. With the development of next-generation molecular profiling methods, our ability to interrogate multiple cancer-associated genomic changes within an individual patient’s tumor has been significantly enhanced. As a result of such advancements, an increasing number of molecular aberrations have now been rendered actionable targets and raise hope of obtaining meaningful and applicable information for treatment individualization.
In this eBook, we explore the opportunities and challenges of precision oncology and how molecular profiling is fundamental not only to inform on tumor diagnosis and prognosis, but also to drive therapeutic decisions in routine clinical care.
Enjoy reading!